Glomela Cream is a topical formulation containing Hydroquinone (2% w/w), Tretinoin (0.025% w/w), and Fluocinolone acetonide (0.01% w/w), indicated for the treatment of melasma and other hyperpigmentation disorders. Hydroquinone acts as a depigmenting agent by inhibiting tyrosinase, thereby reducing melanin synthesis and promoting skin lightening. Tretinoin, a retinoid, enhances epidermal turnover, facilitating the removal of pigmented keratinocytes and improving skin texture. Fluocinolone acetonide, a mild corticosteroid, provides anti-inflammatory effects that help mitigate irritation commonly associated with hydroquinone and tretinoin use. The combination therapy offers a synergistic approach, improving efficacy while minimizing adverse effects. Glomela Cream should be applied once daily at bedtime to the affected areas after cleansing, avoiding contact with eyes and mucous membranes. Patients are advised to use sunscreen and limit sun exposure during treatment to prevent exacerbation of pigmentation. Common side effects include mild erythema, dryness, and peeling, which typically resolve with continued use. This product is contraindicated in individuals with hypersensitivity to any component and should be used cautiously in pregnant or lactating women. Regular dermatological monitoring is recommended to assess treatment response and tolerability.